Stocklytics Platform
Asset logo for symbol MCK
McKesson
MCK64
$715.66arrow_drop_up0.70%$5.00
S&P500
Asset logo for symbol MCK
MCK64

$715.66

arrow_drop_up0.70%

Income Statement (MCK)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
EBIT$1.29B$612.00M$1.15B$1.25B$1.15B
EBITDA$1.44B$775.00M$1.32B$1.41B$1.31B
gross Profit$3.28B$3.24B$2.95B$3.46B$3.15B
NET Income$879.00M$241.00M$915.00M$791.00M$589.00M
total Revenue$95.29B$93.65B$79.28B$76.35B$80.89B

Balance Sheet (MCK)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
cash Equivalents-----
net Debt$8.62B$4.71B$5.09B$2.80B$5.62B
stockholders Equity$5.51B-$3.01B-$1.75B-$1.97B-$2.05B
total Assets$71.08B$72.42B$71.67B$67.44B$66.51B
total Debt$9.75B$7.21B$7.39B$7.39B$7.60B
total Liabilities$73.78B$75.07B$73.05B$69.04B$68.19B

Cash Flow (MCK)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
financing Cash Flow$1.29B-$1.59B-$809.00M-$968.00M-$622.00M
free Cash Flow-$2.38B$2.26B-$1.54B$3.87B$100.00M
investing Cash Flow-----
operating Cash Flow-$2.38B$2.10B-$1.38B$4.14B$254.00M

McKesson (MCK) Financials

McKesson Corp (MCK) is a leading global healthcare company that provides pharmaceuticals, medical supplies, and healthcare information technology. As of the latest financial statement, McKesson Corp reported a total revenue of $231.0 billion. The company's gross profit for the same period stood at $6.8 billion. McKesson Corp recorded an operating income of $5.2 billion, indicating a strong financial performance. The net income attributable to stockholders was reported at $3.9 billion. This shows the company's ability to generate significant profits for its shareholders.
McKesson Corp's balance sheet reflects a healthy financial position. The company has total assets worth $62.8 billion. On the liabilities side, McKesson Corp has a total debt of $30.5 billion, which indicates a moderate debt burden. The stockholders' equity is reported at $17.2 billion, showcasing a solid financial foundation. The company also maintains cash equivalents of $3.6 billion, providing it with liquidity to meet its financial obligations. Additionally, McKesson Corp has a net debt of $26.9 billion, which takes into account the company's cash and cash equivalents.
In terms of cash flow, McKesson Corp has been effectively managing its finances. The operating cash flow for the latest period was $4.2 billion, demonstrating the company's ability to generate cash from its core operations. The investing cash flow stood at -$1.1 billion, primarily driven by investments in property, plant, and equipment. The financing cash flow was reported at -$2.7 billion, reflecting debt repayments and share repurchases. McKesson Corp's free cash flow, which represents the cash available for investment or distribution to stockholders, was $3.0 billion.
In summary, McKesson Corp (MCK) has shown strong financial performance with a substantial total revenue and gross profit. The company maintains a solid balance sheet with a healthy stockholders' equity and manageable debt levels. McKesson Corp has also demonstrated its ability to generate cash from operating activities and maintain a positive free cash flow. Overall, the financials portray McKesson Corp as a financially stable and successful healthcare company.
add McKesson to watchlist

Keep an eye on McKesson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level